Phase I study of ZT-01 for the prevention of hypoglycemia in patients with Type 1 diabetes (T1D) and other types of insulin-dependent diabetes.
Phase of Trial: Phase I
Latest Information Update: 19 Sep 2019
Price : $35 *
At a glance
- Drugs ZT-01 (Primary)
- Indications Hypoglycaemia
- Focus Adverse reactions
- 19 Sep 2019 According to a Zucara Therapeutics media release, this trial is expected to start in early 2020
- 14 Nov 2018 According to a Zucara Therapeutics media release, this trial is expected to start in late 2019.
- 11 Apr 2018 New trial record